CompletedNot Applicable

SWT VERSUS EMFT IN KOA

Egypt60 participantsStarted 2025-01-01

Plain-language summary

The purpose of this study was to compare the effect of extracorporeal shock wave therapy and pulsed electromagnetic field in reducing pain, improving function, and increasing ROM in knee osteoarthritis patients.

Who can participate

Age range

40 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Sixty patients must have a confirmed diagnosis of knee osteoarthritis, specifically those with mild to moderate osteoarthritis.
. Participants must have experienced knee pain lasting more than 3 months.
. Their ages will be ranged from 40 to 60 years.
. Their body mass index within the range of 22.7 to 28.5 kg/m² kg/m².
. Both male and female patients are eligible for the study.
. At least two positive provocative tests, such as joint line tenderness and crepitus, which are commonly associated with knee osteoarthritis.

Exclusion criteria

. Inflammatory arthritis (e.g., rheumatoid arthritis) or other forms of arthritis that are not osteoarthritis.
. Undergone knee replacement surgery or any significant knee surgery within the past year.
. Severe cardiovascular, respiratory, renal, or hepatic diseases that could interfere with study participation or outcomes.
. Received intra-articular corticosteroid injections in the affected knee within the last 3 months.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in physical function.

Timeframe: Pretreatment measurement and posttreatment (4 weeks) measurement.

Change in pain intensity

Timeframe: Pretreatment measurement and posttreatment (4 weeks) measurement.

Change in range of motion.

Timeframe: Pretreatment measurement and posttreatment (4 weeks) measurement.

Trial details

NCT IDNCT07505368

SponsorSuez Canal University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Physical Therapy trials

Who can participate

Age range

40 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Sixty patients must have a confirmed diagnosis of knee osteoarthritis, specifically those with mild to moderate osteoarthritis.
. Participants must have experienced knee pain lasting more than 3 months.
. Their ages will be ranged from 40 to 60 years.
. Their body mass index within the range of 22.7 to 28.5 kg/m² kg/m².
. Both male and female patients are eligible for the study.
. At least two positive provocative tests, such as joint line tenderness and crepitus, which are commonly associated with knee osteoarthritis.

Exclusion criteria

. Inflammatory arthritis (e.g., rheumatoid arthritis) or other forms of arthritis that are not osteoarthritis.
. Undergone knee replacement surgery or any significant knee surgery within the past year.
. Severe cardiovascular, respiratory, renal, or hepatic diseases that could interfere with study participation or outcomes.
. Received intra-articular corticosteroid injections in the affected knee within the last 3 months.

What they're measuring

Change in physical function.

Timeframe: Pretreatment measurement and posttreatment (4 weeks) measurement.

Change in pain intensity

Timeframe: Pretreatment measurement and posttreatment (4 weeks) measurement.

Change in range of motion.

Timeframe: Pretreatment measurement and posttreatment (4 weeks) measurement.